Zoetis | ZTS - Operating Profit



Zoetis reported $1.02B in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
AbbVie USD 5.72B 1.98B Jun/2025
Align Technology USD 163.03M 31.93M Jun/2025
Bayer EUR 13M 2.31B Jun/2025
Bristol-Myers Squibb USD 3.77B 366M Jun/2025
Charles River Laboratories USD 132.33M 57.66M Jun/2025
Dentsply International USD 111M 48M Jun/2025
Eli Lilly USD 7.02B 1.61B Jun/2025
Henry Schein USD -2050000000 2.22B Jun/2025
Idexx Laboratories USD 373.05M 56.51M Jun/2025
Illumina USD 214M 83M Jun/2025
IQVIA Holdings USD 556M 64M Jun/2025
J&J USD 6.94B 6.69B Jun/2025
Laboratory Of America USD 462.8M 130.4M Jun/2025
Merck USD 6.36B 494M Jun/2025
Neogen USD -13254000 18.67M May/2025
Pacira USD 10.23M 8.24M Jun/2025
Perrigo USD 55.6M 23.8M Jun/2025
Pfizer USD 2.6B 1.06B Jun/2025
Quest Diagnostics USD 438M 92M Jun/2025
Sanofi EUR 1.71B 573M Jun/2025
Sanofi EUR 1.71B 851M Jun/2025
Zoetis USD 1.02B 205M Jun/2025